Fundraising FoxSeptal Solutions
Malvern, US · Founded 2020 · Delaware corporation
Find your way into Septal Solutions
Sign up to see every warm intro you have to Septal Solutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Septal Solutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Septal Solutions develops minimally invasive transcatheter devices for treating structural heart disease, aimed at improving patient outcomes through simplified, precise interventions.
Founders & leadership
JK
Jason KeiserSecretary and Treasurer
DW
David WoodChief Medical Officer
GW
Greg WaltersPresident and Chief Executive Officer
EJ
Ehsan JabbarzadehNamed on SEC filing
GC
Grant ConwayNamed on SEC filing
MW
Michael WallaceNamed on SEC filing
Board
GR
Gary RoubinBoard director
Reported raises · per SEC filings
Form D private placements$18.2M disclosed across 5 rounds · 2020–2024
▶$7.3MraisedOct 2026 · 29 investors · Other Health CareRule 506(b)
▶$7.3MraisedOct 2026 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ehsan JabbarzadehDirector
- David WoodDirector
- Grant ConwayDirector
- Greg WaltersExecutive Officer, Director
- Michael WallaceDirector
- Offering amount
- $10M
- Amount sold
- $7.3M
- First sale
- Oct 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.9MraisedNov 2024 · 57 investors · Other Health CareRule 506(b)
▶$10.9MraisedNov 2024 · 57 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David WoodExecutive Officer, Director
- Gary RoubinDirector
- Jason KeiserExecutive Officer, Director
- Greg WaltersExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $10.9M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$410KraisedJul 2024 · 9 investors · Other Health CareRule 506(b)
▶$410KraisedJul 2024 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason KeiserExecutive Officer, Director
- Gary RoubinDirector
- David WoodExecutive Officer, Director
- Greg WaltersExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $410K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$3MraisedMay 2024 · 20 investors · Other Health CareRule 506(b)
▶$3MraisedMay 2024 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Greg WaltersExecutive Officer, Director
- David WoodExecutive Officer, Director
- Jason KeiserExecutive Officer, Director
- Gary RoubinDirector
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2MraisedMay 2024 · 19 investors · Other Health CareRule 506(b)
▶$2MraisedMay 2024 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason KeiserExecutive Officer, Director
- David WoodExecutive Officer, Director
- Gary RoubinDirector
- Greg WaltersExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.9MraisedDec 2022 · 29 investors · Other Health CareRule 506(b)
▶$1.9MraisedDec 2022 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason KeiserExecutive Officer, Director
- Greg WaltersExecutive Officer, Director
- David WoodExecutive Officer, Director
- Gary RoubinDirector
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Septal Solutions do?
- Septal Solutions develops minimally invasive transcatheter devices for treating structural heart disease, aimed at improving patient outcomes through simplified, precise interventions.
- How much funding has Septal Solutions raised?
- Septal Solutions has disclosed $18.2M raised across 5 rounds.
- Where is Septal Solutions headquartered?
- Septal Solutions is headquartered in Malvern, US.